| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 11/15/2007 | WO2007022616A8 Hybrid ultrafast laser surgery and growth factor stimulation for ultra-precision surgery with healing |
| 11/15/2007 | US20070265223 Compositions and methods of enhancing survivability and reducing injury of cells, tissues, organs, and organisms under hypoxic or ischemic conditions |
| 11/15/2007 | US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands |
| 11/13/2007 | US7294348 Polyfunctional biocompatible hydrogel and method for the production thereof |
| 11/13/2007 | CA2442483C 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 11/13/2007 | CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 11/13/2007 | CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 11/12/2007 | WO2007132785A1 Agent for preventing organ adhesion and method for preventing adhesion using the same |
| 11/12/2007 | CA2652322A1 Organ-adhesion preventing agent and process for preventing adhesion using thereof |
| 11/08/2007 | US20070260299 Covalent Grafting of Hydrophobic Substances on Collagen |
| 11/08/2007 | US20070259963 N-[5-methanesulfonyl-4-(4-methanesulfonyl-3-pentafluorosulfanylphenoxy)-2-methyl-benzoyl]guanidine; diagnostic agents for hypertension, diabetes, proliferative disorders; inhibitors of the cellular sodium-proton antiporter (Na/H exchanger); good absorption, bioavailability; angina pectoris, infarction |
| 11/08/2007 | US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases |
| 11/08/2007 | US20070259902 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
| 11/08/2007 | US20070259826 Chimeric (Double) Decoy |
| 11/08/2007 | US20070258942 C-Nitroso compounds and use thereof |
| 11/07/2007 | CN100347192C Collagen and method for producing same |
| 11/01/2007 | WO2007124447A2 Use of chalcogenides for treating shock and other adverse conditions |
| 11/01/2007 | US20070254008 Antibiotic formulation and method of treatment |
| 11/01/2007 | CA2646674A1 Use of chalcogenides for treating shock and other adverse conditions |
| 10/31/2007 | EP1849487A2 Film-forming compositions and methods |
| 10/31/2007 | EP1420801B1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 10/31/2007 | CN101065148A Conjugated complement cascade inhibitors |
| 10/31/2007 | CN101065130A Use of phospholipids for wound healing |
| 10/31/2007 | CN101062051A Injection liquid for vitreous cutting operation and the preparing method thereof |
| 10/31/2007 | CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 10/24/2007 | EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/17/2007 | EP1844734A2 Combination drug therapy for reducing scar tissue formation |
| 10/17/2007 | CN101056662A Adhesion preventive material and method of preventing adhesion |
| 10/11/2007 | WO2007114791A1 Lactate and calcium containing pharmaceutical composition and uses thereof |
| 10/11/2007 | CA2648598A1 Lactate and calcium containing pharmaceutical composition and uses thereof |
| 10/09/2007 | US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression |
| 10/09/2007 | US7279183 Particularly magnesium sulfate, magnesium oxide, magnesium phosphate, or magnesium chloride |
| 10/04/2007 | US20070232614 Therapeutic Agent for Nonviral Hepatitis |
| 10/03/2007 | EP1840208A1 Method of inducing differentiation of skeletal muscle cell |
| 10/03/2007 | EP1021084B1 Solution and process for resuscitation and reparation of ischemically damaged tissue |
| 10/02/2007 | US7276482 Peptide and peptide mimetic derivatives with integrin-inhibitors properties II |
| 10/02/2007 | US7276364 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/25/2007 | CA2301183C Pharmacologic drug combination in vagal-induced asystole |
| 09/19/2007 | CN101036667A Gelatin for preventing conglutination in the surgical and the method for preparing the same |
| 09/19/2007 | CN101036666A Liquid for preventing conglutination in the surgical and the method for preparing the same |
| 09/13/2007 | WO2007087241A3 Treatment of ischemic disease using thrombopoietin |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1830856A2 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems |
| 09/12/2007 | EP1519962B1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/05/2007 | EP1827456A1 Use of phospholipids for wound healing |
| 09/05/2007 | EP1206275B1 Irrigation solution and method for inhibition of pain and inflammation |
| 09/05/2007 | CN101028283A Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 09/05/2007 | CN101028280A Lavage liquor preparation for operation and its production |
| 09/04/2007 | US7265124 Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound |
| 08/30/2007 | US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/29/2007 | EP1826213A1 Rapamycin analogs containing an antioxidant moiety |
| 08/29/2007 | EP1826212A1 Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same |
| 08/29/2007 | EP1826211A1 Isomers and 42-Epimers of rapamycin alkyl ether analogs, methods of making and using the same |
| 08/29/2007 | EP1347754B1 Compositions for adhesion prevention |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | CN100333804C Sodium hyaluronate anti-adhesion film, and its prepn. method |
| 08/23/2007 | WO2006093276A8 Pluripotent stem cell derived from cardiac tissue |
| 08/23/2007 | DE102006006904A1 Neue Mittel zur Blutstillung und Klebstoffe für medizinische Anwendungen Novel agents for hemostasis and adhesives for medical applications |
| 08/16/2007 | US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release |
| 08/15/2007 | EP1465676B1 Film-forming compositions and their uses |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/09/2007 | WO2007089103A1 Composition for inhibiting adhesion |
| 08/09/2007 | WO2007073186A3 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 08/09/2007 | WO2006114105A8 Use of modified factor vii for treating bleeding |
| 08/09/2007 | CA2640409A1 Composition for inhibiting adhesion |
| 08/08/2007 | CN101011576A Compositions and methods for treating or preventing inflammatory diseases |
| 08/07/2007 | CA2407952C Growth factor modified protein matrices for tissue engineering |
| 08/02/2007 | WO2007087241A2 Treatment of ischemic disease using thrombopoietin |
| 08/02/2007 | CA2636426A1 Treatment of ischemic disease using thrombopoietin |
| 08/01/2007 | EP1813294A1 Adhesion preventive and method of preventing adhesion |
| 07/26/2007 | US20070173518 Crystal of ticagrelor; G-protein coupled receptor antagonist, used for treating arterial thrombotic complications |
| 07/26/2007 | US20070172512 administering Lactobacillus paracasei that is capable of adhering to the intestine's mucosa and essentially colonizing it for the preparation of an ingestable carrier; liver cirrhosis |
| 07/25/2007 | CN1328285C Inhibitor of stem cell proliferation and uses thereof |
| 07/25/2007 | CN101002934A Compound cardiografin slow-releasing preparation for treating posto-lymphatic fistula and pancreas fistula, and its preparing method |
| 07/19/2007 | WO2007080898A1 Sustained-release hydrogel preparation |
| 07/18/2007 | EP0859751B2 Semi-fluorinated alkanes and their use |
| 07/18/2007 | CN1326855C Ring fused pyrazole derivatives |
| 07/18/2007 | CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/05/2007 | WO2006045963A3 Composition of cosmetic or pharmacological application for stimulation of synthesis of collagen |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/03/2007 | US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 06/28/2007 | WO2007073186A2 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 06/28/2007 | CA2632400A1 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 06/27/2007 | EP1801123A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 06/27/2007 | CN1985905A Chinese medicine preparation for preventing and treating intestinal adhesion after abdominal cavity operation and its preparing process and application |
| 06/26/2007 | US7235532 Angiogenic agents and their uses |
| 06/22/2007 | CA2550417A1 Method for maintaining cerebral hemispheric oxygen saturation during surgery |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/07/2007 | WO2006127907A3 Localized delivery of cardiac inotropic agents |
| 06/06/2007 | CN1319540C Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/29/2007 | US7223391 Administering subject's modified blood on consecutive days; blood is modified extracorporeally by exposure from 2 to 5 minutes to a combination of stressors; treating ischemic stress, atherosclerosis and rheumatoid arthritis |